Viewing StudyNCT01803425



Ignite Creation Date: 2024-05-06 @ 1:26 AM
Last Modification Date: 2024-10-26 @ 11:03 AM
Study NCT ID: NCT01803425
Status: WITHDRAWN
Last Update Posted: 2013-09-09
First Post: 2013-02-28

Brief Title: Post-marketing Safety Study of GlaxoSmithKline GSK Biologicals Synflorix Vaccine in Healthy Infants and Children in Sri Lanka
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-04
Start Date Type: None
Primary Completion Date: 2014-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2014-04
Completion Date Type: ESTIMATED
First Submit Date: 2013-02-28
First Submit QC Date: February 28 2013
Study First Post Date: 2013-03-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-09-05
Last Update Post Date: 2013-09-09
Last Update Post Date Type: ESTIMATED